James Kim, MD
Hospitalist · Salisbury, NCNPI 1386684330
Payments from drug & device makers
Across 132 payments — averaging $14.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$329
- Novartis$322
- GSK$243
- AbbVie$172
- Novo Nordisk$162
- Mannkind Corporation$101
- plus $644 from 20 others
What the payments were for
- Consulting fees$251%
- Food & beverage$1,94999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 26 | $329 |
| Novartis | 20 | $322 |
| GSK | 17 | $243 |
| AbbVie | 10 | $172 |
| Novo Nordisk | 6 | $162 |
| Mannkind Corporation | 7 | $101 |
| Eisai Inc. | 6 | $77 |
| Astellas Pharma US Inc | 5 | $66 |
| Amarin Pharma, Inc. | 4 | $58 |
| Sanofi-aventis U.S. LLC | 4 | $55 |
| Daiichi Sankyo Inc. | 3 | $50 |
| UCB, Inc. | 3 | $46 |
| Johnson & Johnson(2 entities) | 3 | $40 |
| Merck | 3 | $39 |
| Sanofi Pasteur Inc. | 1 | $25 |
| AstraZeneca | 2 | $24 |
| Boehringer Ingelheim | 2 | $24 |
| Lilly USA, LLC | 2 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tresiba$122
How this compares
$1,974 in reported general payments places this provider in the 85th percentile of 879 hospitalist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 12 | $397 |
| Losartan Potassium | 12 | $330 |
| Sertraline Hcl | 15 | $285 |
| Lovastatin | 12 | $281 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Salisbury
- Honnie SpencerSalisbury$50K
- Kevin CannonWilmington$47.5M
- Emily Ray KoDurham$182K
- Mahesh ChandrasekharWinston Salem$100K
- Dwan VarnerGreenville$59K
- Adaorah OkaforWinston Salem$53K
- Jenna BrooksCharlotte$24K
- Ria DancelChapel Hill$13K
- Javad MonzavifarCharlotte$12K
- Bikki GautamCharlotte$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.